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Diarrhoea as a result of gastrointestinal tract 
infections is a significant problem facing much of 
Africa.[1] In 2000 alone, almost 4% of the deaths in 
South Africa (SA) were attributable to infectious 
diarrhoea, representing the fifth leading cause of 
years of life lost.[2] The causes of infectious diarrhoea are varied. 
Nosocomial infections are chiefly caused by Clostridium difficile 
and to a lesser extent by Klebsiella oxytoca, typically after anti­
biotic therapy, which allows the organisms to proliferate and cause 
disease.[3] Community­acquired diarrhoea resulting from person­
to­person transmission or the consumption of contaminated and 
poorly prepared foodstuffs and water can be caused by a range of 
bacterial agents. These include several pathotypes of Escherichia 
coli, non­typhoidal Salmonella spp., Shigella spp., enterotoxigenic 
Bacteroides fragilis, Campylobacter spp. and Staphylococcus aureus, 
as well as several viruses (rotavirus, norovirus and adenovirus) and 
parasites (e.g. Giardia lamblia and Entamoeba spp.).[4]
Despite their potential to cause disease, there have been relatively 
few SA studies examining the prevalence of pathogenic micro­
organisms in ‘non­outbreak’ situations, particularly in the hospital 
environment. In addition, the majority of surveillance studies 
have examined paediatric populations that are at increased risk of 
developing diarrhoeal disease. There is little information regarding 
the prevalence of potential pathogens in adults. The aim of this 
study was therefore to identify the prevalence of a selected panel of 
potential pathogenic bacteria in routine stool samples provided by 
patients with diarrhoea attending Groote Schuur Hospital (GSH), 
Cape Town, SA.
Methods
Sample collection and study participants
Stool samples (N=139) were collected as part of a larger study from 
in­ and outpatients presenting to GSH with diarrhoea between March 
2012 and March 2013. Patients <16 years old were excluded from the 
study. Samples were transferred to the National Health Laboratory 
Service (NHLS) unit at GSH, where they were stored at –20°C until 
further processing. The presence of blood in stool samples was 
assessed visually. Ethics approval was obtained from the University 
of Cape Town, Human Research Ethics Committee (HREC Number 
310/2008).
Genomic DNA extraction
Total faecal genomic DNA was extracted from stool samples using the 
GXT Stool Extraction Kit (Hain Lifesciences, SA) and the GenoXtract 
automated extraction instrument following the manufacturer’s 
instructions. The quantity and purity of the DNA were assessed using 
a Nanodrop 1000 instrument (Nanodrop, USA). The quality of the 
genomic DNA and the absence of polymerase chain reaction (PCR) 
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pathogens were present at low frequencies (0 ­ 2.9%), and the occurrence of mixed infections was 5%. The majority of non­C. difficile­related 
diarrhoeas were community acquired.
Conclusion. C. difficile was the main cause of infectious diarrhoea in the sampled patients, while K. oxytoca and EPEC/EHEC strains were 
present as relatively minor but potentially significant pathogens.
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inhibitors were further assessed by PCR amplification of each sample 
using 50 ng template and the F27/R5 primer pair, which target the 
bacterial 16S rRNA gene.
Preparation of positive amplification controls
Bacterial­specific genomic DNA for use as a positive amplification 
control in the PCR screening amplifications was prepared from 
pure cultures of C. difficile (toxigenic isolate R20291), C. jejuni (a 
laboratory isolate provided by the NHLS, SA), S. aureus (a laboratory 
isolate) and S. enterica subsp. enterica serovar Typhimurium (ATCC 
14028), using a genomic DNA extraction kit (ThermoScientific, 
USA) following the manufacturer’s instructions. For the B. fragilis bft 
screening experiment, plasmids containing the cloned target region 
of the bft-1 subtype (prepared in this study) and the bft-2 subtype 
(kindly provided by Prof. Cynthia Sears), were used as positive 
amplification controls.[5] Plasmids containing cloned target regions 
of K. oxytoca (pehX), enteropathogenic and enterohaemorrhagic 
Escher ichia coli (EPEC/EHEC) (eaeA) and the various pathogenic 
Shigella spp. (invC) were used as positive amplifications controls in 
the respective reactions.
Screening for potential pathogens
Total faecal genomic DNA (50 ng) prepared from each stool sample 
was used as template in a series of PCR amplifications using primers 
specific to each pathogen (Table 1). No template control reactions 
were included for each different primer set. PCR cycling parameters 
for the universal bacterial 16S rRNA gene, C. jejuni/C. coli, S. aureus, 
Salmonella spp., Shigella spp., K. oxytoca and EHEC/EPEC reactions 
were as follows: denaturation at 95°C for 5 minutes, followed by 35 
cycles of denaturation at 94°C for 30 seconds, annealing at primer­
specific temperature for 30 seconds, and extension at 72°C for 1 
minute, and finally 72°C for 7 minutes.
Table 1. Primers used in this study
Primer Sequence (5ʹ - 3ʹ)
Annealing 
temperature 
(°C) Target/description
Size 
(bp) Reference
F27 AGA GTT TGA TCI TGG CTC AG 55 Bacterial 16S rRNA gene 1 500 18
R5 ACG GIT ACC TTG TTA CGA CTT
Tpi­F AAA GAA GCT ACT AAG GGT ACA AA 65 ­ 55* C. difficile tpi gene 230 3
Tpi­R CAT AAT ATT GGG TCT ATT CCT AC
TcdA­F AGA TTC CTA TAT TTA CAT GAC AAT AT 65 ­ 55* C. difficile tcdA gene 369/110† 3
TcdA­R GTA TCA GGC ATA AAG TAA TAT ACT TT
TcdB­F GGA AAA GAG AAT GGT TTT ATT AA 65 ­ 55* C. difficile tcdB gene 160 3
TcdB­R ATC TTT AGT TAT AAC TTT GAC ATC TTT
GBF­201 GAA CCT AAA ACG GTA TAT GT 62 Common forward 
primer
19
GBF­312 CCT CTT TGG CGT CGC Reverse primer for bft-1 
gene
190
GBF­322 CGC TCG GGC AACT AT Reverse primer for bft-2 
gene
175
GBF­334 TGT CCC AAG TTC CCC AG Reverse primer for bft-3 
gene
287
Peh­C GAT ACG GAG TAT GCC TTT ACG GTG 59 K. oxytoca pehX 
polygalacturonase gene
344 20
Peh­D TAG CCT TTA TCA AGC GGA TAC TGG
eaeA­F ATG CTT AGT GCT GGT TTA GG 58 EHEC/EPEC E. coli eaeA 
intimin gene
248 11
eaeA­R GCC TTC ATC ATT TCG CTT TC
CCCJ609­F AAT CTA ATG GCT TAA CCA TTA 58 C. jejuni/C. coli 16S 
rRNA gene
854 21
CCCJ1442­R GTA ACT AGT TTA GTA TTC CGG
nuc­F GCG ATT GAT GGT GAT ACG GTT 55 S. aureus nuc gene 280 22
nuc­R AGC CAA GCC TTG ACG AAC TAA AGC
invA­F GTG AAA TTA TCG CCA CGT TCG GGC AA 64 Salmonella spp. invA 
gene
281 23
invA­R TCA TCG CAC CGT CAA AGG AAC C
SgenDF1 TGC CCA GTT TCT TCA TAC GC 60 Shigella spp. invC gene 875 24
SgenDR1 GAA AGT AGC TCC CGA AAT GC
bp = base pairs.
*Touchdown PCR procedure: An initial annealing temperature of 65°C dropping to 55°C by 1°C per cycle for the first 11 cycles.
†The full­length tcdA gene fragment is 369 bp, whereas the truncated tcdA gene fragment in toxin A – B + C. difficile strains is 110 bp.
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Multiplex PCR reactions were used to screen for bft­positive 
B. fragilis strains and toxigenic C. difficile. For the B. fragilis bft 
screening protocol, a common forward primer and three specific 
reverse primers that target the three different bft subtypes were 
used. The PCR cycling parameters were as follows: denaturation at 
95°C for 5 minutes, followed by 35 cycles of denaturation at 94°C 
for 1 minute, annealing at 62°C for 30 seconds and extension at 
72°C for 1 minute, and finally 72°C for 7 minutes. For the C. difficile 
screening protocol, primers targeting the species­specific tpi gene 
as well as the two toxin genes tcdA and tcdB were used to identify 
toxigenic strains. A touchdown PCR procedure was employed. An 
initial denaturation at 95°C for 5 minutes was performed, followed 
by 40 cycles of denaturation at 95°C for 30 seconds, annealing for 30 
seconds at temperatures decreasing from 65°C to 55°C (decreasing 
by 1°C per cycle for the first 11 cycles) and extension at 72°C for 
30 seconds. A final extension step was then carried out at 72°C for 
7 minutes. All reaction products were analysed by electrophoresis 
through 2% (w/v) agarose gels and imaged using a ChemiDoc EC 
imager (Bio­rad, SA). Positive controls (50 ng of pure genomic DNA 
from target strains or 50 ng of plasmid DNA containing the relevant 
target fragment) and negative controls containing no template were 
included in each PCR experiment.
Results
Basic demographic data
A total of 139 stool samples were analysed, of which 80 (57.6%) were 
from female patients. Patient ages ranged from 16 to 87 years, with 
the majority of the patients (73%) between 20 and 60 years of age.
Prevalence of selected pathogenic bacteria in  
diarrhoea samples
All samples showed the predicted 1.5 kb product when screened using 
the universal bacterial 16S rRNA gene primers (result not shown). 
Each of the primer sets gave the specific, expected product when used 
to amplify control target DNA under the study conditions (Fig. 1). The 
results of screening the study samples are summarised in Fig. 2. Of the 
139 samples screened, 53 (approximately 38%) contained one or more 
of the target organisms possibly linked to the patient symptoms, while 
the remainder gave a negative result reflecting a diarrhoea of unknown 
origin. Toxigenic C. difficile was the most prevalent potential pathogen. 
It was found in approximately 16% of samples overall and in all age 
groups except the 16 ­ 20 years group. EPEC/EHEC E. coli were present 
in approximately 9% of cases and occurred across all age groups. K. 
oxytoca and S. aureus both occurred in 6% of samples, Salmonella 
spp., Shigella spp., and bft­positive B. fragilis together were present 
in approximately 8% of the samples, and Campylobacter spp. were 
not detected in any of them (Fig. 2). Mixed populations of potential 
pathogens were found in approximately 5% of the samples. Of the 
patient cohort, ten individuals (7%) showed evidence of blood in their 
stool. Two of these stools came from patients colonised by Shigella spp. 
and one from a patient colonised by S. aureus, while the remaining 
seven bloody stools did not contain any of the pathogens included in 
the screening procedures.
Discussion
Routine surveillance of bacteria that are known agents of infectious 
diarrhoea is very seldom carried out for organisms other than Shigella 
spp. and non­typhoidal Salmonella spp. In this study, we sought to 
examine the prevalence of other potential bacterial pathogens present 
in diarrhoea samples from patients attending a hospital in Cape 
Town. The results suggested that C. difficile was the most prevalent 
pathogen among patients in the 21 ­ 87­year­old range, with the 
rest of the selected potential pathogens making up a relatively small 
percentage of the cases.
C. difficile is a frequent cause of nosocomial diarrhoea, accounting 
for up to 20% of such cases worldwide.[3] There have also been 
reports suggesting that the prevalence of community­acquired cases 
of C. difficile is increasing.[6] Importantly, there are few data on 
the prevalence of C. difficile in SA. A previous study, also carried 
out at GSH but employing an enzyme­immunoassay (EIA)­based 
technique, determined a prevalence of 9.2% for toxigenic C. difficile 
in patients with diarrhoea.[7] It is possible, however, that some C. 
difficile cases were overlooked in this earlier study, as EIA­based tests 
have been reported to suffer from inferior diagnostic sensitivity.[8] 
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Fig. 1. Positive control reactions for each primer set. Lanes: Mw (100 bp DNA ladder), Cd (C. difficile), Bf1 (B. fragilis bft­1), Bf2 (B. fragilis bft­2), Ko (K. 
oxytoca), Ec (EHEC/EPEC E. coli), Sl (Salmonella spp.), Sg (Shigella spp.), Cm (C. jejuni/C. coli), Sa (S. aureus).
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The only other PCR­based analysis reported a prevalence of 11.4% 
of toxigenic C. difficile in individuals with diarrhoea in the Vhembe 
district, suggesting that C. difficile­related infections are an important 
but possibly under­reported cause of diarrhoea in SA.[9] A more 
detailed analysis of the prevalence and epidemiology of C. difficile at 
GSH as well as a comparison of various diagnostic testing modalities 
is currently being prepared for publication.
Pathogenic E. coli are traditionally divided into several different 
pathotypes. While enteroaggregative E. coli are increasingly recog­
nised as an important cause of diarrhoea in both Africa and the rest 
of the world, their broad genetic diversity means that in order to 
detect them using a PCR­based screening method, several primer 
combinations detecting different targets need to be employed.[10] 
We therefore limited our screening procedure to detect EPEC and 
EHEC strains, both of which have been known to cause outbreaks of 
diarrhoea in Africa and can be detected by the presence of the eaeA 
gene.[11] In the current study, EPEC and EHEC strains were present 
in just under 9% of the diarrhoea cases. Of these cases, 8/12 (67%) 
developed prior to hospital admission, suggesting that the majority 
of the E. coli infections were community acquired. Blood in the stool 
was not evident in any of the patients colonised by EPEC/EHEC 
strains. A previous study by Bisi­Johnson et al.[12] identified EPEC 
and EHEC strains in approximately 13% of patients with diarrhoea 
attending a tertiary hospital in the Eastern Cape Province, SA. 
However, that study had a large proportion of young patients (30% of 
the patients were between the ages of 7 and 13), who are at increased 
risk of developing E. coli­related diarrhoea.
K. oxytoca has been implicated as a cause of antibiotic­associated 
haemorrhagic colitis. Clinical isolates have been shown to 
constitutively produce β­lactamases, which confer resistance to both 
amino­ and carboxypenicillins and allow the organism to survive 
antibiotic therapy and initiate infection.[13] A small proportion of 
healthy individuals (1.6%) are asymptomatic carriers of K. oxytoca, 
although the carriage rate in non­symptomatic patients attending 
GSH is currently unknown.[14] None of the samples positive for 
K. oxytoca showed evidence of blood in the stool, suggesting that 
K. oxytoca was not a major cause of diarrhoea among the patients 
examined.
Non­typhoidal Salmonella spp. and Shigella spp. are responsible 
for a significant number of cases of diarrhoea in Africa and are 
regarded by the World Health Organization as organisms of global 
significance.[1,15] Shigella spp. in particular have been known to 
cause outbreaks of bloody diarrhoea among adults in much of the 
developing world.[4] Of the four patients colonised by pathogenic 
Shigella spp., two showed strong evidence of blood in the stool. 
Although occasional nosocomial outbreaks have been reported 
in SA, both pathogens are predominantly acquired through the 
ingestion of contaminated food and water or from person­to­
person transmission via the faecal­oral route. In the current study, 
all the diarrhoea cases in which either pathogen was present 
Fig. 2. Prevalence of selected pathogenic bacteria in diarrhoea samples. The numbers of samples containing the selected pathogen are given next to the 
histograms for each age group. Samples that did not contain any of the selected pathogens investigated in the study were reported as ‘Unknown’.
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were community acquired. However, the combined prevalence of 
approximately 5% suggests that neither pathogen was a major cause 
of diarrhoea in the sample group.
B. fragilis is a human gut commensal that is also able to cause 
opportunistic invasive infections. In addition, certain strains also 
produce a metalloprotease enterotoxin encoded by the bft gene that 
enables the bacterium to cause diarrhoea.[5] Screening of the samples 
in the current study using primers that target all three subtypes of the 
bft gene revealed a low prevalence of bft­positive B. fragilis strains.
Enterotoxin­producing S. aureus is a fairly rare cause of diarrhoea, 
but is of particular significance in the hospital environment owing to 
its role in postoperative infections. There have also been reports that 
many samples from patients with antibiotic­associated diarrhoea that 
were positive for enterotoxin­producing S. aureus were also positive 
for C. difficile.[16] In the current study, 5/8 (62.5%) of the samples 
positive for S. aureus also harboured at least one of the other potential 
pathogens that were included in the screen. C. difficile was co­present 
in three of these samples and is presumed to be the main cause of 
diarrhoea in these patients. It is not clear from these results whether 
the presence of S. aureus promoted colonisation by other potential 
pathogens or vice versa.
In developing countries, Campylobacter spp., predominantly C. jejuni 
and C. coli, are the most common bacterial cause of diarrhoea in 
babies in the first year of life.[4] A previous study by Samie et al.[17] repor­
ted prevalences of 12.5% and 7% for C. jejuni and C. coli, respectively, 
among patients between the ages of 0 and 88 attending hospitals in 
the Venda region of SA. However, in the patient group examined 
in our study, it was not possible to detect either species in the stool 
samples using the described primer set, the specificity of which was 
validated using the C. jejuni­positive control DNA.
An initial screening of the purified DNA using universal primers 
targeted to the bacterial 16S rRNA gene yielded positive products 
for each of the samples, indicating that the quality of the extracted 
DNA was suitable for PCR analysis. However, it is possible that in 
cases where targets were not abundant in the samples, these may not 
have been detected by the individual PCR screening experiments. 
In addition, other bacterial strains, parasites and viruses as well 
as non­infectious factors (e.g. direct gut toxicity of administered 
antibiotics) were not included in this pilot study and are reflected 
as being of unknown origin (Fig. 2). These might be contributing 
to the diarrhoea cases observed and should be included in further 
studies. In particular, protocols to detect the prevalence of rotavirus 
(which has an RNA not a DNA genome) should be used during stool 
analysis. Nevertheless, the results presented here suggest that, in 
addition to C. difficile, other bacterial pathogens such as EPEC/EHEC 
strains that are not routinely screened for in the hospital setting may 
be responsible for a number of episodes of diarrhoea among adults in 
SA, and this warrants further investigation.
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